Cancer is a complex problem. The ultimate aim of cancer research is to eradicate this common and devastating disease from the human population. The international effort to understand and control it involves clinicians trained in many branches of medicine and scientists from most organic disciplines, interaction, medicinal and physical sciences. All of these goals depend on a grouping of basic and functional research. Cancers Review will be a gateway from which cancer researchers from those investigating the molecular basis of cancer to those involved in translational research appetizer the information that they need to additional the aptitude to classify, treat and ultimately prevent cancer. Cancers Review is a peer-reviewed and international journal.  It publishes reviews and regular research papers.

Subject Areas

  • Adenoma 
  • Alternative Therapy for Cancer 
  • Anal Cancer
  • Basal Cell Carcinoma Benign Tumors
  • Bladder Cancer
  • Bone Cancer
  • Brachytherapy Brain Cancer
  • Breast Cancer
  • Breast Cancer, Male 
  • Bronchogenic Carcinoma 
  • Cancer
  • Cancer Alternative Therapies
  • Cancer, Benign 
  • Cancer Chemotherapy
  • Cancer in Children
  • Cancer--Living with Cancer
  • Carcinoid Tumors
  • Carcinoma 
  • Cervical Cancer
  • Chemotherapy 
  • Childhood Brain Tumors
  • Childhood Leukemia 
  • Colon Cancer 
  • Colonic Polyps
  • Colonoscopy 
  • Colorectal Cancer
  • Endometrial Cancer 
  • Esophageal Cancer
  • Ewing’s Sarcoma 
  • Eye Cancer
  • Gallbladder Cancer
  • Gastric Cancer 
  • Gastrointestinal Stromal Tumors 
  • Glioma 
  • Hairy Cell Leukemia 
  • Head and Neck Cancer
  • Hepatoblastoma 
  • Hepatocellular Carcinoma 
  • Hodgkin’s Disease
  • Hypernephroma 
  • Intestinal Cancer
  • Intraocular Melanoma 
  • Islet Cell Carcinoma 
  • Kaposi’s Sarcoma
  • Kidney Cancer
  • Larynx Cancer 
  • Leukemia, Adult Acute
  • Leukemia, Adult Chronic
  • Leukemia, Childhood
  • Liver Cancer
  • Living with Cancer 
  • Lung Cancer
  • Lymphoma
  • Male Breast Cancer
  • Malignancy 
  • Melanoma
  • Meningioma 
  • Merkel Cell Cancer 
  • Mesothelioma
  • Multiple Myeloma
  • Nasal Cancer
  • Neoplasms 
  • Nephroblastoma 
  • Neuroblastoma
  • Neurofibromatosis
  • Non-Hodgkin’s Lymphoma 
  • Non-Small Cell Lung Cancer 
  • Oncology 
  • Oral Cancer
  • Osteosarcoma 
  • Ovarian Cancer
  • Paget’s Disease of Breast 


  • Pancreatic Cancer
  • PAP Smear 
  • Paranasal Sinus Cancer 
  • Pharynx Cancer 
  • Pheochromocytoma
  • Plasma-cell Myeloma 
  • Plasmacytoma 
  • Prostate Cancer
  • Radiation Therapy
  • Radiosurgery 
  • Radiotherapy 
  • Rectal Cancer 
  • Renal Cancer 
  • Retinoblastoma 
  • Rhabdomyosarcoma 
  • Sarcoma, Ewing’s 
  • Sarcoma, Soft Tissue 
  • Skin Cancer
  • Small Cell Lung Cancer 
  • Small Intestine Cancer 
  • Soft Tissue Sarcoma
  • Stomach Cancer
  • Testicular Cancer
  • Throat Cancer 
  • Thymus Cancer
  • Thyroid Cancer
  • Tumor 
  • Tumors, Benign 
  • Ureteral Cancer 
  • Urethral Cancer 
  • Urinary Bladder Cancer 
  • Uterine Cancer
  • Vaginal Cancer
  • von Recklinghausen’s Disease 
  • Vulvar Cancer
  • Wilms’ Tumor


We would like to invite you to contribute papers for consideration and publication in the Cancers Review (CR).It is published on biannually (June and December). All submitted articles should be original and must not be under consideration for publication elsewhere. Manuscripts should follow the formatting style of the journal. CR reviews papers within approximately 35 working days of submission and publishes accepted articles in the relevant forthcoming issues upon receiving the final versions.

Related Information

  1. Submission Acknowledgement: When you submit a manuscript online, you will receive a submission acknowledgement letter sent by the online system automatically. For email submission, the editor or editorial assistant sends an e-mail confirmation to the submission’s author within one to three working days.
  2. First Review: The editor or editorial assistant decides whether the article fits the journal’s aims and scope. Next a checked for the similarity rate is completed using CrossCheck, powered by iThenticate. Any manuscripts out of the journal’s scope or having plagiarism, including self-plagiarism, are rejected without peer reviewed.
  3. Peer Review and Decision of Reviewer: The CR is following double-blind system for peer-review; both reviewers and authors’ identities remain anonymous. The paper will be peer-reviewed by three experts; two reviewers from outside and one editor from the journal typically involve in reviewing a submission. The review process may take 3-5 weeks. The result of review will be sent to the corresponding author by email, and he/she will be assumed to send other authors.
  4. Average Time: The average time between submission and final decision is 35 working days and the average time between acceptance and final publication is 30 to 40 days.
  5. Article Publication Fee:  The journal does not have any Article Processing Charges and will publish well-prepared manuscripts free of cost submitted in 2023. However, if any manuscript requires English language editing and proofreading, a nominal fee will be charged based on the length of the manuscript. 
  6. DOIs at the article Level: Each paper published in Cancers Review is assigned a DOI number, Click HERE to know what is DOI (Digital Object Identifier).
  7. Publication Notice: The author(s) will be informed by email, when his/her article published online on the journal website.
  8. High Visibility: indexed in the RePec, Ideas, Scilit, Google Scholar, Academic Informa  and abstract videos are available at YouTube channel .
  9. CB Publication Ethics Statement: Cancers Review is following the Publication Ethics guideline of Committee on Publication Ethics (COPE). Please read the Publication Ethics and Malpractice Statement of CR.
  10. Journal Membership: Cancers Review is  a member of Cross ref.
  11. Copyright and Reprint Permission: All Rights is Reserved by Conscientia Beam. Abstracting or Indexing is allowed with acknowledgment to the journal source. The personal use of the journal articles is acceptable. However, approval to reprint/republish this material for advertising or promotional purposes or for creating new collective works for resale or redistribution to servers or lists, or to reuse any copyrighted component of this work in other works must be obtained from the journal.
  12. Special Issues: Guest Editors are kindly invited to produce Special Issues consisting of articles organized around a theme of particular interest. These special issues are often edited by guest editors who are not on the editorial board. Proposals for Special Issues are most welcomed as a Guest Editorials and Announcements.
  13. Announcement and Advertisement: Announcements regarding academic activities such as conferences are published for free. Advertisement can be either published or placed on the related website. Contact e-mail address by email:

Bibliographic Information

Cancers Review
Online ISSN: 2408-9273
Print ISSN: 2409-2053
Journal DOI: 10.18488/journal.95